What's Happening With AbbVie Stock?

This article was originally published on Nasdaq

AbbVie stock (NYSE: ABBV) reported its Q2 results last week, with revenue falling short and earnings above the street estimates. ABBV stock fell around 7% in a week, while it’s down 8% in a month. The company reported revenue of $14.6 billion (up 4.5% y-o-y) and EPS of $3